【発明の名称】組合せ化学療法 - SMITHKLINE BEECHAM CORPORATION

Title:

【発明の名称】組合せ化学療法

Document Type and Number:

Japanese Patent JPH07501079

Kind Code:

A

Abstract:

A pharmaceutical composition comprising a compound of the camptothecin analog class and a platinum coordination compound and a pharmaceutically acceptable carrier or diluent; a method of inhibiting the growth of tumor cells in a human afflicted therewith which comprises administering to such human an effective tumor cell growth inhibiting amount of such pharmaceutical composition; and a method of inhibiting the growth of tumor cells in a human afflicted therewith which comprises administering to such human an effective tumor cell growth inhibiting amount of the combination of a compound of the camptothecin analog class and a platinum coordination compound.

More Like This:

WO/2011/158206	AN ANTITUMORAL COMBINATION COMPRISING OMBRABULIN, A TAXANE DERIVATIVE AND A PLATINUM DERIVATIVE
JP6328590	Crystalline N-{(1S) -2-amino-1-[(3-fluorophenyl) methyl] ethyl} -5-chloro-4- (4-chloro-1-methyl-1H-pyrazole-5-yl) -2-Thiophene carboxamide hydrochloride
JP7148604	4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds as CDK inhibitors

Inventors:

Johnson, Randall Keith

Application Number:

JP50945493A

Publication Date:

February 02, 1995

Filing Date:

November 13, 1992

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SMITHKLINE BEECHAM CORPORATION

International Classes:

A61K31/282; A61K31/47; A61K31/28; A61K31/4745; A61K31/555; A61K33/243; A61K45/06; A61P35/00; (IPC1-7): A61K31/47; A61K31/28

Attorney, Agent or Firm:

Aoyama Ryo (1 person outside)

Previous Patent: JPH07501078

Next Patent: JPH07501080